AGTR1 and sarcopenia: Indeed, we demonstrated that PWH using AT1R blockers presented reduced skeletal muscle AT1R expression compared to PWH not using any antihypertensive drugs, suggesting that AT1R activation occurs in the skeletal muscle of PWH and that it is linked to muscle weakness and sarcopenia in this population.